bpc 157 chronic pancreatitis Peptides, explained: Answers to your top questions JPP No 5/2013 article 09

In the future, high-quality research needs to be further carried out to clarify its clinical positioning and safety, so as to promote its rational application in digestive system diseases

Use of BPC-157 occurs outside approved regulatory frameworks, either as part of research protocols or through compounding pharmacies and research chemical suppliers

Hepatocyte growth factor inhibits anoikis of pancreatic carcinoma cells through phosphatidylinositol 3-kinase pathway

It feeds follicles by prompting new blood vessels, it blocks a signal called TGF-beta that makes follicles shrink early, and it props up the dermal papilla cells that drive new growth